Recent AML Launches – What Have We Learned?
Recent Launches for Acute Myeloid Leukemia (AML) What We’ve Learned Advancements in medicine have equipped physicians to assign distinct prognostic groups to patients with AML [...]
Recent Posts
Medimix joins Evidera, a business unit of Pharmaceutical Product Development, (PPD) expanding solutions for Real-World Research
Enhances Medimix and Evidera’s ability to leverage data to provide …Medimix Recognized by PharmaTech Outlook: “Top 10 Analytics Solution Provider to Pharma and Life Sciences Europe – 2019”
For the second year in a row, Medimix International has …
Jean-Jacques Borie Appointed Medimix SVP Innovation
Medimix International Expands Its Executive Team Jean-Jacques Borie Joins as …
Medimix Honored for LiveTracker RWD Solution
The crucial importance of Real World Evidence
Health-care is an essential factor in human lives. Every hospital, …